Ligand validation:6FPO

LMT: DODECYL-BETA-D-MALTOSIDE

LMT is a Ligand Of Interest in 6FPO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6FPO_LMT_S_404	58%	21%	0.091	0.925	0.88	2.38	1	7	0	0	69%	0.54
6FPO_LMT_T_404	22%	40%	0.15	0.875	0.71	1.62	-	3	0	0	40%	0.4
6G7R_LMT_T_404	32%	80%	0.119	0.897	0.4	0.45	-	-	0	0	40%	0.24
3USE_LMT_S_405	24%	70%	0.165	0.902	0.13	1.01	-	1	7	0	40%	0.28
4GD3_LMT_B_302	14%	66%	0.237	0.849	0.43	0.88	-	2	0	0	66%	0.6571
6RP2_LMT_S_404	9%	44%	0.185	0.734	0.68	1.46	-	6	1	0	69%	0.4114
6FPW_LMT_T_404	8%	84%	0.178	0.75	0.4	0.37	-	-	1	0	40%	0.24
5NV9_LMT_A_504	99%	31%	0.045	0.983	0.57	2.12	-	12	1	0	100%	1
3CAY_LMT_A_512	94%	59%	0.071	0.968	0.66	0.9	-	1	0	0	100%	1
4U8Y_LMT_C_1101	83%	64%	0.096	0.953	0.43	0.92	-	1	2	0	100%	1
3SZF_LMT_A_501	73%	33%	0.101	0.928	1.23	1.44	3	5	2	0	100%	1
3T14_LMT_A_501	72%	31%	0.12	0.945	1.21	1.54	3	10	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.